Combined Treatment Modalities in Esophageal Cancer: Should chemotherapy be included?

References

• Rosenberg J C, Lichter A S, Leichman L P. Cancer of the esophagus. Cancer: Principles & practice of oncology, ed. 3, V T DeVita, Jr, S Hellman, S A Rosenberg. Lippincott, Philadelphia 1989; 725–64
   Google Scholar
• Hansson L E, Sparén P, Nyrén O. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer 1993; 54: 402–7
   PubMed Web of Science ®Google Scholar
• Hesketh P, Clapp R W, Doos W G, Spechler S J. Increasing frequency of adenocarcinomas of the esophagus. Cancer 1989; 64: 526–30
   PubMed Web of Science ®Google Scholar
• Blot W J, Devesa S S, Knel Jer R W, Fraumeni J F, Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287–9
   PubMed Web of Science ®Google Scholar
• Earlam R, Cunha-Melo J R. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980; 67: 381–90
   PubMed Web of Science ®Google Scholar
• Saeger H D, Nagel M, Trede M. Ergebnisse in der chirurgi-schen Therapie des Oesophaguscarcinomas. Langenbecks Arch Chir 1987; 372: 161–4
   PubMedGoogle Scholar
• O'Rourke I C, Johnson D C, Tiver K W. Management of oesophageal cancer at Westmead Hospital from 1979–1985. Med J Aust 1988; 148: 450–6
   PubMedGoogle Scholar
• Mathiesen D J, Grillo H C, Wilkins E W, Jr, Moncure A C, Hilgenberg A D. Transthoracic esophagectomy: A safe approach to carcinoma of the esophagus. Ann Thorac Surg 1988; 45: 137–43
   PubMedGoogle Scholar
• Müller J M, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845–57
   PubMed Web of Science ®Google Scholar
• De-Ren S. Ten-year follow-up of esophageal cancer treated by radical radiation therapy: Analysis of 869 patients. Int J Radiat Oncol Biol Phys 1989; 16: 329–34
   PubMed Web of Science ®Google Scholar
• Earlam R, Cunha-Melo J R. Oesophageal squamous cell carcinoma: II. A critical review of radiotherapy. Br J Surg 1980; 67: 457–61
   PubMed Web of Science ®Google Scholar
• Newaishy G A, Read G A, Duncan W, Kerr G R. Results of radical radiotherapy of squamous cell carcinoma of the oesophagus. Clin Radiol 1982; 33: 347–52
   PubMed Web of Science ®Google Scholar
• Slevin N J, Stout R. Carcinoma of the oesophagus—a review of 108 cases treated by radical radiotherapy. Clin Radiol 1989; 40: 200–3
   PubMedGoogle Scholar
• Earlam R. An MRC prospective randomised trial of radiotherapy versus surgery for operable squamous cell carcinoma of the oesophagus. Ann R Col Surg Engl 1991; 73: 8–12
   PubMedGoogle Scholar
• Launois B, Delarue D, Campion J P, Kerbaol M. Preopera-tive radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 1981; 53: 690–2
   Google Scholar
• Gignoux M, Roussel A, Paillot B. The value of preoperative radiotherapy in esophageal cancer: Results of a study of the EORTC. World J Surg 1987; 11: 426–32
   PubMed Web of Science ®Google Scholar
• Arnott S J, Duncan W, Kerr G R. Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomised clinical trial. Radiother Oncol 1992; 24: 108–13
   PubMed Web of Science ®Google Scholar
• Mei W, Xian-Zhi G, Weibo Y, Guojun H, Liang-Jun W, Da-Wei Z. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: Report on 206 patients. Int J Radiat Oncol Biol Phys 1989; 16: 325–7
   PubMedGoogle Scholar
• Shao L, Gao Z, Yang N, Wei G, Wang Y, Cheng C. Results of surgical treatment in 6 123 cases of carcinoma of the esophagus and gastric cardia. J Surg Oncol 1989; 42: 170–4
   PubMedGoogle Scholar
• Nygaard K, Hagen S, Hansen H S. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992; 16: 1104–9
   PubMed Web of Science ®Google Scholar
• Kasai M, Mori S, Watanabe T. Follow-up results after resection of thoracic esophageal carcinoma. World J Surg 1978; 2: 543–51
   PubMedGoogle Scholar
• Iizuka T, Ide H, Kakegawa T. Preoperative radioactive therapy for esophageal carcinoma. Randomized evaluation trial in eight institutions. Chest 1988; 93: 1054–8
   PubMedGoogle Scholar
• Teniere P, Hay J M, Fingerhut A, Fagniez P L. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet 1991; 173: 123–30
   PubMedGoogle Scholar
• Fok M, Sham J ST, Choy D, Cheng S WK, Wong J. Postoperative radiotherapy for carcinoma of the esophagus: A prospective, randomized controlled study. Surgery 1993; 113: 138–47
   PubMed Web of Science ®Google Scholar
• Appelqvist P. Carcinoma of the oesophagus and gastric cardia at autopsy in Finland. Ann Clin Res 1975; 7: 334–40
   PubMedGoogle Scholar
• Anderson L L, Lad T E. Autopsy findings in squamous-cell carcinoma of the esophagus. Cancer 1982; 50: 1587–90
   PubMed Web of Science ®Google Scholar
• Mandard A M, Chasle J, Marnay J. Autopsy findings in 111 cases of esophageal cancer. Cancer 1981; 48: 329–35
   PubMed Web of Science ®Google Scholar
• Kelsen D. Chemotherapy of esophageal cancer. Semin Oncol 1984; 11: 159–68
   PubMed Web of Science ®Google Scholar
• Engstrom P F, Lavin P T, Klaassen D J. Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma. Cancer Treat Rep 1983; 67: 713–5
   PubMedGoogle Scholar
• Advani S H, Saikia T K, Swaroop S. Anterior chemotherapy in esophageal cancer. Cancer 1985; 56: 1502–6
   PubMedGoogle Scholar
• Sternberg C, Kelsen D, Dukeman M, Leichman L, Heelan R. Carboplatin: A new platinum analog in the treatment of epidermoid carcinoma of the esophagus. Cancer Treat Rep 1985; 69: 1305–7
   PubMedGoogle Scholar
• Mannell A, Winters Z. Carboplatin in the treatment of oesophageal cancer. S Afr Med J 1989; 76: 213–4
   PubMed Web of Science ®Google Scholar
• Nanus D M, Kelsen D P, Lipperman R, Eisenberger M. Phase II trial of ifosfamide in epidermoid carcinoma of the esophagus: unexpectant severe toxicity. Invest New Drugs 1988; 6: 239–41
   PubMedGoogle Scholar
• Ansell S M, Alberts A S, Falkson G. Ifosfamide in advanced carcinoma of the esophagus: A phase II trial with severe toxicity. Am J Clin Oncol 1989; 12: 205–7
   PubMedGoogle Scholar
• Harstrick A, Bokemeyer C, Preusser P. Phase II study of single-agent Etoposide in patients with metastatic squamous-cell carcinoma of the esophagus. Cancer Chemother Pharmacol 1992; 29: 321–2
   PubMed Web of Science ®Google Scholar
• Bleiberg H, Jacob J H, Bedenne L, Paillot B, De Besi P, Lacave A. Randomized phase II trial of 5-fluorouracil (5-FLf) and cisplatin (DDP) versus DDP alone in advanced esophageal cancer. Proc Am Soc Clin Oncol 1991; 10: 145
   Google Scholar
• Lovett D, Kelsen D, Eisenberger M, Houston C. A phase II trial of carboplatin and vinblastine in the treatment of advanced squamous cell carcinoma of the esophagus. Cancer 1991; 67: 354–6
   PubMedGoogle Scholar
• Kolaric K, Maricic Z, Roth A, Dujmovic I. Combination of bleomycin and adriamycin with and without radiation in the treatment of inoperable esophageal cancer. A randomized study. Cancer 1980; 45: 2265–73
   PubMedGoogle Scholar
• Coonley C J, Bains M, Hilaris B, Chapman R, Kelsen D P. Cisplatin and bleomycin in the treatment of esophageal cancer: A final report. Cancer 1984; 54: 2351–5
   PubMedGoogle Scholar
• Bosset J, Hurteloup P, Bontemas P. A phase II trial of bleomycin and cisplatin in advanced oesophagus carcinoma. Proc. of the 13th International Cancer Congress. 1983; 41
   Google Scholar
• Bromer R, Abbruzzese J, Karp D, Paquette D, Snow M, Hong W. Ineffectiveness of cisplatin-bleomycin induction chemotherapy for esophageal carcinoma. Proc Am Soc Clin Oncol 1984; 3: 143
   Google Scholar
• Marcuello E, Alba E, Gómez de Segura G. Cisplatin and intravenous continuous infusion of bleomycin in advanced and metastatic esophageal cancer. Eur J Cancer Clin Oncol 1988; 24: 633–5
   PubMedGoogle Scholar
• Izquierdo M A, Marcuello E, Gomez de Segura G. Unresectable nonmetastatic squamous cell carcinoma of the esophagus managed by sequential chemotherapy (cisplatin and bleomycin) and radiation therapy. Cancer 1993; 17: 287–92
   Google Scholar
• Kok T C, Splinter T AW, Verweij J. Etoposide and cisplatin in advanced esophageal cancer. Acta Oncol 1988; 27: 807–9
   PubMed Web of Science ®Google Scholar
• Anderson N, Lokich J, Moore C, Bern M, Zipoli T. Infu-sional etoposide and cisplatinum with and without flox-uridine in gastroesophageal cancer. Proc Am Soc Clin Oncol 1990; 9: 127
   Google Scholar
• Kies M S, Rosen S T, Tsang T-K. Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer. Cancer 1987; 60: 2156–60
   PubMed Web of Science ®Google Scholar
• Hilgenberg A D, Carey R W, Wilkins E W, Jr, Choi N C, Mathisen D J, Grillo H C. Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg 1988; 45: 357–63
   PubMed Web of Science ®Google Scholar
• De Besi P, Toso S, Chiarion Sileni V. Multimodality therapy for unresectable squamous cell carcinoma of the esophagus (ESSC). Proc Am Soc Clin Oncol 1990; 9: 129
   Google Scholar
• Margolin K, Doroshow J, Leong L. Combination chemotherapy with cytosine arabinoside (Ara-C) and cis-diammmedichloroplatinum (CDDP) for squamous cancers of the upper aerodigestive tract. Am J Clin Oncol 1989; 12: 494–7
   PubMed Web of Science ®Google Scholar
• Batist G, Boos G, Gonzales-Vela L, Kinnear D G, Mulder D S. Cytosine arabinoside (Ara-C) by continuous infusion (CI) and cisplatin in unresectable squamous cell carcinoma of esophagus. Proc Am Soc Clin Oncol 1989; 8: 116
   Google Scholar
• Trudeau M, Batist G, Thirlwell M, Boos G, Shennib H, Mulder D. Neoadjuvant chemotherapy with cytosine arabinoside (ARA-C) by continuous infusion (CI) and cisplatinum (CDDP) for resectable squamous cell carcinoma (SCC) of the esophagus. Proc Am Soc Clin Oncol 1991; 10: 144
   Google Scholar
• Vogl S E, Greenwald E, Kaplan B H. Effective chemotherapy for esophageal cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II. Cancer 1981; 48: 2555–8
   PubMedGoogle Scholar
• De Besi P, Salvagno L, Endrizzi L. Cisplatin, bleomycin and methotrexate in the treatment of advanced oesophageal cancer. Eur J Cancer Clin Oncol 1984; 20: 743–7
   PubMedGoogle Scholar
• Gisselbrecht C, Calvo F, Mignot L. Fluorouracil (F), adriamycin (A), and cisplatin (P) (FAP): Combination chemotherapy of advanced esophageal carcinoma. Cancer 1983; 52: 974–7
   PubMed Web of Science ®Google Scholar
• Elias D, Lasser P, Kac J. Cancers epidermoides de l'oesophage: Association chimiotherapie, chirurgie et radio-therapie. Resultats preliminaires sur 50 cas. Bull Cancer 1988; 75: 175–81
   PubMedGoogle Scholar
• Kelsen D P, Fein R, Coonley C, Heelan R, Bains M. Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer. Cancer Treat Rep 1986; 70: 255–9
   PubMedGoogle Scholar
• Forastiere A A, Gennis M, Orringer M B, Agha F P. Cisplatin, vinblastine, and mitoguazone chemotherapy for epidermoid and adenocarcinoma of the esophagus. J Clin Oncol 1987; 5: 1143–9
   PubMedGoogle Scholar
• Dinwoodie W R, Bartolucci A A, Lyman G H, Velez-Garzia E, Martelo O J, Sarma P R. Phase II evaluation of cisplatin, bleomycin, and vindesine in advanced squamous cell carcinoma of the esophagus: A Southeastern Cancer Study Group Trial. Cancer Treat Rep 1986; 70: 267–70
   PubMedGoogle Scholar
• Roth J A, Pass H I, Flanagan M M, Graeber G M, Rosenberg J C, Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988; 96: 242–8
   PubMed Web of Science ®Google Scholar
• Kelsen D, Hilaris B, Coonley C. Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma. Am J Med 1983; 75: 645–52
   PubMed Web of Science ®Google Scholar
• Schlag P, Herrmann R, Raeth V, Lehner B, Schwarz V, Herfarth C. Preoperative chemotherapy in esophageal cancer. A phase II study. Acta Oncol 1988; 27: 811–4
   PubMed Web of Science ®Google Scholar
• Kelsen D P, Minsky B, Smith M. Preoperative therapy for esophageal cancer: A randomized comparison of chemotherapy versus radiation therapy. J Clin Oncol 1990; 8: 1352–61
   PubMed Web of Science ®Google Scholar
• Spielman M, Guillot T, Kac J. Phase II trial of cisplatin (P) and continuous infusion (CI) of bleomycin (B) and 5 fluorouracil (F) in advanced esophageal cancer (ESO C). Proc Am Soc Clin Oncol 1989; 8: 102
   Google Scholar
• Preusser P, Wilke H, Achterrath W. Disease oriented phase II study with cisplatin (P), etoposide (E), and 5-FU (F)= PEF in advanced squamous cell carcinoma of the esophagus. Proc Am Soc Clin Oncol 1988; 7: 101
   Google Scholar
• Lester E P, Pate J W, Memula N G, Paig C U, Norfleet L F. Esophageal carcinoma: Results of initial chemotherapy with methotrexate (MTX) leucovorin (L), cisplatinum (CCDP), and 5-fluorouracil (5-FU). Proc Am Soc Clin Oncol 1990; 9: 115
   Google Scholar
• Vogl S E, Camacho F, Berenzweig M, Ruckdeschel J. Chemotherapy for esophageal cancer with mitoguazone, methotrexate, bleomycin, and cisplatin. Cancer Treat Rep 1985; 69: 21–3
   PubMedGoogle Scholar
• Kelsen D, Atiq O T. Therapy of upper gastrointestinal tract cancers. Curr Probl Cancer 1991; 15: 239–94
   Google Scholar
• Queisser W, Preusser P, Mross K B. Phase II evaluation of carboplatin in advanced esophageal carcinoma. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer Society. Onkologie 1990; 13: 190–3
   PubMedGoogle Scholar
• Vadi H, Drewinko B. Kinetics and mechanism of the 1-β-D-arabinofuranosylcytosine-induced potentiation of cisdiamminedichloroplatinum (II) cytotoxicity. Cancer Res 1986; 46: 1105–9
   PubMed Web of Science ®Google Scholar
• Swinnen L J, Barnes D M, Fisher S G, Albain K S, Fisher R I, Erickson L C. l-β-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cisdiamminedichlorplatinum (II) and modification of platinum-induced DNA interstrand cross-linking. Cancer Res 1989; 49: 1383–9
   PubMedGoogle Scholar
• Kelsen D, Lovett D, Wong J. Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer. J Clin Oncol 1992; 10: 269–74
   PubMedGoogle Scholar
• Wadler S, Fell S, Haynes M. Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferon. Cancer 1993; 71: 1726–30
   PubMedGoogle Scholar
• Fujimaki M, Soga J, Kawaguchi M. Role of preoperative administration of bleomycin and radiation in the treatment of esophageal cancer. Jap J Surg 1975; 5: 48–55
   PubMedGoogle Scholar
• Miller J I, McLntyre B, Hatcher C R, Jr. Combined treatment approach in surgical management of carcinoma of the esophagus: a preliminary report. Ann Thorac Surg 1985; 40: 289–93
   PubMedGoogle Scholar
• Carey R W, Hilgenberg A D, Grillo H C, Mathisen D J, Choi N C, Logan D L. Esophageal carcinoma: long term follow-up of patients treated by neo-adjuvant chemotherapy, surgery and possible postoperative radiation and/or chemotherapy. Proc Am Soc Clin Oncol 1990; 9: 105
   Google Scholar
• Coonley C J, Bains M, Hilaris B, Chapman R, Kelsen D P. Cisplatin and bleomycin in the treatment of esophageal carcinoma. A final report. Cancer 1984; 54: 2351–5
   PubMedGoogle Scholar
• Schlag P M. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg 1992; 127: 1446–50
   PubMedGoogle Scholar
• Andersen A P, Berdal P, Edsmyr F. Irradiation, chemotherapy and surgery in esophageal cancer: A randomized clinical study. Radiother Oncol 1984; 2: 179–88
   PubMedGoogle Scholar
• Werner I D. Multidisciplinary approach to the management of carcinoma of the oesophagus. Digestion 1977; 6: 284
   Google Scholar
• Gignoux M, Bosset J F. Adjuvant therapy for resectable oesophageal cancer: Results of a pilot study. Anticancer Res 1989; 9: 1023–4
   PubMedGoogle Scholar
• Leichman L, Steiger Z, Seydel H G. Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: A potentially curative approach. J Clin Oncol 1984; 2: 75–9
   PubMed Web of Science ®Google Scholar
• Poplin E, Fleming T, Leichman L. Combined therapies for squamous-cell carcinoma of the esophagus—a Southwest Oncology Group Study (SWOG-8037). J Clin Oncol 1987; 5: 622–8
   PubMed Web of Science ®Google Scholar
• Seydel H G, Leichman L, Byhardt R. Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: A RTOG study. Int J Radiat Oncol Biol Phys 1988; 14: 33–5
   PubMedGoogle Scholar
• Richmond J, Seydel H G, Bae Y, Lewis J, Burdakin J, Jacobsen G. Comparison of three treatment strategies for esophageal cancer within a single institution. Int J Radiat Oncol Biol Phys 1987; 13: 1617–20
   PubMedGoogle Scholar
• Austin J C, Postier R G, Elkins R C. Treatment of esophageal cancer: The continued need for surgical resection. Am J Surg 1986; 152: 592–6
   PubMedGoogle Scholar
• Campbell W R, Jr, Taylor S A, Pierce G E, Hermreck A S, Thomas J H. Therapeutic alternatives in patients with esophageal cancer. Am J Surg 1985; 150: 665–8
   PubMedGoogle Scholar
• Mercke C, Albertsson M, Hambraeus G. Cisplatinum and 5-FU combined with radiotherapy and surgery in the treatment of squamous cell carcinoma of the esophagus. Palliative effects and tumor response. Acta Oncol 1991; 30: 617–22
   PubMed Web of Science ®Google Scholar
• Santoro A, Bidoli P, Valente M. Multimodality therapy for squamous cell carcinoma of the esophagus (SCCE). Proc Am Soc Clin Oncol 1989; 8: 112
   Google Scholar
• Carter P, Burton G, Wolfe W. Squamous cell carcinoma of the esophagus: effective multimodal therapy. Proc Am Soc Clin Oncol 1989; 8: 104
   Google Scholar
• Franklin R, Steiger Z, Vaishampayan G. Combined modality therapy for esophageal squamous cell carcinoma. Cancer 1983; 51: 1062–71
   PubMed Web of Science ®Google Scholar
• Parker E F, Reed C E, Marks R D, Kratz J M, Connolly M. Chemotherapy, radiation therapy, and resection for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1989; 98: 1037–44
   PubMedGoogle Scholar
• Stewart F M, Harkins B J, Hahn S S, Daniel T M. Cisplatin, 5-fluorouracil, mitomycin C, and concurrent radiation therapy with and without esophagectomy for esophageal carcinoma. Cancer 1989; 64: 622–8
   PubMedGoogle Scholar
• MacFarlane S D, Hill L D, Jolly P C, Kozarek R A, Anderson R P. Improved results of surgical treatment for esophageal and gastroesophageal junction carcinomas after preoperative combined chemotherapy and radiation. J Thorac Cardiovasc Surg 1988; 95: 415–22
   PubMed Web of Science ®Google Scholar
• Forastiere A A, Orringer M B, Perez-Tamayo C. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol 1990; 8: 119–27
   PubMed Web of Science ®Google Scholar
• Orringer M B, Forastiere A A, Perez-Tamayo C, Urba S, Takasugi B J, Bromberg J. Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma. Ann Thorac Surg 1990; 49: 348–55
   PubMed Web of Science ®Google Scholar
• Forastiere A A, Orringer M B, Perez-Tamayo C, Urba S G, Zahurak M. Preoperative chemoradiation followed by tran-shiatal esophagectomy for carcinoma of the esophagus: Final report. J Clin Oncol 1993; 11: 1118–23
   PubMed Web of Science ®Google Scholar
• Popp M B, Hawley D, Reising J. Improved survival in squamous esophageal cancer. Preoperative chemotherapy and irradiation. Arch Surg 1986; 121: 1330–5
   PubMedGoogle Scholar
• Doggett R LS, Guernsey J M, Bagshaw M A. Combined radiation and surgical treatment of carcinoma of the thoracic esophagus. Front Radiat Ther Oncol 1970; 5: 147–54
   Google Scholar
• Goodner J T. Surgical and radiation treatment of cancer of the thoracic esophagus. Am J Roentg Radiat Ther Nucl Med 1969; 105: 523–8
   PubMedGoogle Scholar
• Marks R D, Jr, Scruggs H J, Wallace K M. Preoperative radiation therapy for carcinoma of the esophagus. Cancer 1976; 38: 84–9
   PubMed Web of Science ®Google Scholar
• Parker E F, Gregorie H B, Prioleau W H, Jr, Marks R D, Bartles D M. Carcinoma of the esophageus. Observations of 40 years. Ann Surg 1982; 195: 618–23
   PubMed Web of Science ®Google Scholar
• Sugimachi K, Matsufuji H, Kai H. Preoperative irradiation for carcinoma of the esophagus. Surg Gynecol Obstet 1986; 162: 174–6
   PubMedGoogle Scholar
• Rich T A, Lokich J J, Chaffey J T. A pilot study of protracted venous infusion of 5-fluorouracil and concomitant radiation therapy. J Clin Oncol 1985; 3: 402–6
   PubMed Web of Science ®Google Scholar
• Lokich J J, Shea M, Chaffey J. Sequential infusional 5-fluorouracil followed by concomitant radiation for tumors of the esophagus and gastroesophageal junction. Cancer 1987; 60: 275–9
   PubMed Web of Science ®Google Scholar
• Roth J A, Ajani J A, Rich T A. Multidisciplinary therapy for esophageal cancer. Adv Surg 1990; 23: 239–60
   PubMedGoogle Scholar
• Byfield J E, Calabro-Jones P, Klisak I, Kulhanian F. Phar-macologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur x-rays. Int J Radiat Oncol Biol Phys 1982; 8: 1923–33
   PubMed Web of Science ®Google Scholar
• Leichman L. Cancer of the esophagus: The Wayne State University experience. Invest New Drugs 1989; 7: 91–100
   PubMedGoogle Scholar
• Naunheim K S, Petruska P J, Roy T S. Preoperative chemotherapy and radiotherapy for esophageal carcinoma. J Thorac Cardiovasc Surg 1992; 103: 887–95
   PubMedGoogle Scholar
• Earle J D, Gelber R D, Moertel C G, Hahn R G. A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 1980; 6: 821–6
   PubMedGoogle Scholar
• Kolaric K, Maricic Z, Dujmovic I, Roth A. Therapy of advanced esophageal cancer with bleomycin, irradiation and combination of bleomycin with irradiation. Tumori 1976; 62: 255–62
   PubMed Web of Science ®Google Scholar
• Byfield J E, Barone R, Mendelsohn J. Infusional 5-fluorouracil and x-ray therapy for non-resectable esophageal cancer. Cancer 1980; 45: 703–8
   PubMed Web of Science ®Google Scholar
• Roussel A, Bleiberg H, Dalesio O. Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: Final results of a controlled clinical trial. Int J Radiat Oncol Biol Phys 1989; 16: 67–72
   PubMedGoogle Scholar
• Seitz J F, Giovannini M, Padaut-Cesana J. Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy. Cancer 1990; 66: 214–9
   PubMedGoogle Scholar
• Wolfe W G, Burton G V, Seigler H F, Crocker I R, Vaughn A L. Early results with combined modality therapy for carcinoma of the esophagus. Ann Surg 1987; 205: 563–71
   PubMedGoogle Scholar
• Chan A, Wong A, Arthur K. Concomitant 5-fluorouracil infusion, mitomycin C and radical radiation therapy in esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1989; 16: 59–65
   PubMedGoogle Scholar
• Keane T J, Harwood A R, Elhakim T. Radical radiation therapy with 5-fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma. Radiother Oncol 1985; 4: 205–10
   PubMedGoogle Scholar
• Coia L R, Engstrom P F, Paul A. Nonsurgical management of esophageal cancer: Report of a study of combined radiotherapy and chemotherapy. J Clin Oncol 1987; 5: 1783–90
   PubMed Web of Science ®Google Scholar
• Leichman L, Herskovic A, Leichman C G. Nonopera-tive therapy for squamous-cell cancer of the esophagus. J Clin Oncol 1987; 5: 365–70
   PubMed Web of Science ®Google Scholar
• John M J, Flam M S, Ager Mowry P. Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation. Cancer 1989; 63: 2397–403
   PubMed Web of Science ®Google Scholar
• Abitbol A, Straus M J, Franklin G, Billet D, Sullivan P, Moran R E. Infusional chemotherapy and cyclic radiation therapy in inoperable esophageal and gastric cardia carcinoma. Am J Clin Oncol 1983; 6: 195–201
   PubMedGoogle Scholar
• Marcial V A, Vélez-Garcia E, Cintrón J, Ydrach A A. Radiotherapy preceeded by multidrug chemotherapy in carcinoma of the esophagus. A pilot study of the Radiation Therapy Oncology Group. Cancer Clin Trials 1980; 3: 127–30
   PubMedGoogle Scholar
• Hatlevoll R, Hagen S, Sand Hansen H. Bleomycin/cis-platin as neoadjuvant chemotherapy before radical radiotherapy in localized, inoperable carcinoma of the esophagus. Radiother Oncol 1992; 24: 114–6
   PubMedGoogle Scholar
• Kolaric K, Maricic Z, Roth A, Dujmovic J. Adriamycin alone and in combination with radiotherapy in the treatment of inoperable esophageal cancer. Tumori 1977; 63: 485–91
   PubMedGoogle Scholar
• Araiújo C MA, Souhami L, Gil R A. A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 1991; 67: 2258–61
   PubMedGoogle Scholar
• Herskovic A, Martz K, Al-Sarraf M. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593–8
   PubMed Web of Science ®Google Scholar
• Kolaric K, Zupanc D, Zivkovic M. Radiation alone vs radiochemotherapy (DDP + 5-FU) in locoregional advanced esophageal cancer—interim report of a prospective randomized study. Proc Am Soc Clin Oncol 1992; 11: 175
   Google Scholar
• Sischy B, Ryan L, Haller D. Interim report of EST 1282 phase III protocol for the evaluation of combined modalities in the treatment of patients with carcinoma of the esophagus, stage I & II. Proc Am Soc Clin Oncol 1990; 9: 105
   Google Scholar
• Coia L R. Contributions of radiotherapy and chemo-radio-therapy in esophageal cancer. Proc International Conference on Biology and Treatment of Gastrointestinal Malignancies. 1992; 19
   Google Scholar
• Gill P G, Denham J W, Jamieson G G, Devitt P G, Yeoh E, Olweny C. Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery. J Clin Oncol 1992; 10: 1037–43
   PubMedGoogle Scholar
• Albertsson M, Ewers S-B, Widmark H, Hambraeus G, Lillo-Gil R, Ranstam J. Evaluation of the palliative effect of radiotherapy for esophageal carcinoma. Acta Oncol 1989; 28: 267–70
   PubMed Web of Science ®Google Scholar
• Elkon D, Lee M-S, Hendrickson F R. Carcinoma of the esophagus: Sites of recurrence and palliative benefits after definitive radiotherapy. Int J Radiat Oncol Biol Phys 1978; 4: 615–20
   PubMedGoogle Scholar
• van Andel J G, Dees J, Dijkhuis C M. Carcinoma of the esophagus. Results of treatment. Ann Surg 1979; 190: 684–9
   PubMedGoogle Scholar
• Petrovich Z, Lam K, Langholz B, Formenti S, Luxton G, Tildon T. Surgical therapy and radiotherapy for carcinoma of the eosophagus. J Thorac Cardiovasc Surg 1989; 98: 614–7
   PubMedGoogle Scholar
• Jobsen J J, van Andel J G, Eijkenboom W MH. Carcinoma of the esophagus: Treatment results. Radiother Oncol 1986; 5: 101–8
   PubMed Web of Science ®Google Scholar
• Beatty J D, De Boer G, Rider W D. Carcinoma of the esophagus. Pretreatment assessment, correlation of radiation treatment parameters with survival, and identification and management of radiation treatment failure. Cancer 1979; 43: 2254–67
   PubMed Web of Science ®Google Scholar
• Hussey D H, Barkley H T, Jr, Bloedorn F G. Carcinoma of the esophagus. Textbook of radiotherapy, G H Fletcher. Lea & Febiger, Philadelphia 1980; 688–703
   Google Scholar
• Kelsen D P, Ahuja R, Hopfan S. Combined modality therapy of esophageal carcinoma. Cancer 1981; 48: 31–7
   PubMed Web of Science ®Google Scholar
• Nakayama K, Kinoshita Y. Surgical treatment combined with preoperative concentrated irradiation. JAMA 1974; 227: 178–81
   PubMed Web of Science ®Google Scholar
• Groves L K, Rodriguez-Antunez A. Treatment of carcinoma of the esophagus and gastric cardia with concentrated preoperative irradiation followed by early operation. Ann Thorac Surg 1973; 15: 333–8
   PubMedGoogle Scholar
• Akakura I, Nakamura Y, Kakegawa T, Nakayama R, Watanabe H, Yamashita H. Surgery of carcinoma of the esophagus with preoperative radiation. Chest 1970; 57: 47–57
   PubMed Web of Science ®Google Scholar
• Girling D J, Clark P J. Randomized trials in the treatment of cancer of the esophagus. J Clin Oncol 1992; 10: 1031–3
   PubMedGoogle Scholar
• A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Japanese Esophageal Oncology Group. Chest 1993; 104: 203–7
   PubMedGoogle Scholar
• Connors J M, Andiman W A, Howarth C B. Treatment of nasopharyngeal carcinoma with human leukocyte inter-feron. J Clin Oncol 1985; 3: 813–7
   PubMedGoogle Scholar
• Ikic D, Padovan I, Brodarec I, Knezevic M, Soos E. Application of human leucocyte interferon in patients with tumours of the head and neck. Lancet 1981; 1: 1025–7
   PubMed Web of Science ®Google Scholar
• Lippman S M, Kessler J F, Meyskens F L, Jr. Retinoids as preventive and therapeutic anticancer agents (part II). Cancer Treat Rep 1987; 71: 493–515
   PubMedGoogle Scholar